Karishma Rajani

709 citations

22 papers · 500 indexed · h-index 12

Co-authors: Richard G. Vile Alan Melcher Elizabeth J. Ilett Jill Thompson Shane Zaidi Kevin G. Shim Kevin J. Harrington Timothy Kottke
Topics: Virus-based gene therapy research (13 papers)Immunotherapy and Immune Responses (10 papers)Cancer Research and Treatments (6 papers)
Cited by: Genetics Oncology Biotechnology
Journals: Cancer Research Journal of Virology International Journal of Radiation Oncology*Biology*Physics
Partner nations: United States United Kingdom Canada

In The Last Decade

Karishma Rajani

21 papers receiving 492 citations

Peers

Countries citing papers authored by Karishma Rajani

Since Specialization

Citations

This map shows the geographic impact of Karishma Rajani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karishma Rajani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karishma Rajani more than expected).

Fields of papers citing papers by Karishma Rajani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karishma Rajani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karishma Rajani. The network helps show where Karishma Rajani may publish in the future.

Co-authorship network of co-authors of Karishma Rajani

This figure shows the co-authorship network connecting the top 25 collaborators of Karishma Rajani. A scholar is included among the top collaborators of Karishma Rajani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karishma Rajani. Karishma Rajani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Injury-like Signature of the Extracellular Glioma Metabolome 2024 ·Cancers ·(unknown),Karishma Rajani,(unknown),(unknown),(unknown),(unknown),Mark A. Schroeder,Moses Rodriguez,Arthur E. Warrington,Terry C. Burns	1
2	Methodological and analytical considerations for intra-operative microdialysis 2023 ·Fluids and Barriers of the CNS ·(unknown),Karishma Rajani,(unknown),Ju‐Hee Oh,Desmond Brown,(unknown),Benjamin Himes,Ignacio Jusué-Torres,Moses Rodriguez,Arthur E. Warrington,Sani H. Kizilbash,William F. Elmquist,Terry C. Burns	4
3	An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence 2023 ·npj Precision Oncology ·(unknown),Lucas P. Carlstrom,Bryan J. Neth,(unknown),Karishma Rajani,(unknown),(unknown),Moustafa Mansour,Bipasha Mukherjee,Arthur E. Warrington,Susan Short,Thomas von Zglinicki,Desmond Brown,Sandeep Burma,Tamar Tchkonia,Marissa J. Schafer,Darren J. Baker,Sani H. Kizilbash,James L. Kirkland,Terry C. Burns	14
4	Methods for intratumoral microdialysis probe targeting and validation in murine brain tumor models 2021 ·Journal of Neuroscience Methods ·Karishma Rajani,(unknown),Joshua J. Jacobs,(unknown),(unknown),Lucas P. Carlstrom,Mark A. Schroeder,Ju‐Hee Oh,Charles L. Howe,(unknown),Jann N. Sarkaria,William F. Elmquist,Terry C. Burns	4
5	Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma 2019 ·Frontiers in Oncology ·Karishma Rajani,Lucas P. Carlstrom,Ian F. Parney,Aaron J. Johnson,Arthur E. Warrington,Terry C. Burns	21
6	Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy 2017 ·Molecular Therapy ·Kevin G. Shim,Shane Zaidi,Jill Thompson,Tim Kottke,Laura Evgin,Karishma Rajani,Matthew Schuelke,Christopher B. Driscoll,Amanda L. Huff,José S. Pulido,Richard G. Vile	19
7	Immunogenicity of self tumor associated proteins is enhanced through protein truncation 2016 ·Molecular Therapy — Oncolytics ·Tim Kottke,Kevin G. Shim,Vanesa Alonso-Camino,Shane Zaidi,Rosa María Díaz,José S. Pulido,Jill Thompson,Karishma Rajani,Laura Evgin,Elizabeth J. Ilett,Hardev Pandha,Kevin J. Harrington,Peter J. Selby,Alan Melcher,Richard G. Vile	3
8	Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy 2016 ·Gene Therapy ·Elizabeth J. Ilett,Tim Kottke,Jill Thompson,Karishma Rajani,S. Zaidi,Laura Evgin,Matt Coffey,Christy Ralph,(unknown),H. Pandha,Kevin J. Harrington,Peter J. Selby,Richard J. Bram,Alan Melcher,Richard G. Vile	59
9	64. Generation of Tumor Cells Resistant to Oncolysis Is Mediated Through Virus Induced APOBEC Expression 2016 ·Molecular Therapy ·Karishma Rajani,Kevin G. Shim,(unknown),(unknown),Tim Kottke,(unknown),Christopher B. Driscoll,(unknown),Richard G. Vile	1
10	Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses 2015 ·Molecular Therapy ·Karishma Rajani,Christopher Parrish,Timothy Kottke,Jill Thompson,Shane Zaidi,Elizabeth J. Ilett,Kevin G. Shim,(unknown),Hardev Pandha,Kevin J. Harrington,Matt Coffey,Alan Melcher,Richard G. Vile	154
11	Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling 2015 ·Neuro-Oncology ·Julia Cockle,Karishma Rajani,Shane Zaidi,Timothy Kottke,Jill Thompson,Rosa María Díaz,Kevin G. Shim,Tim Peterson,Ian F. Parney,Susan Short,Peter J. Selby,Elizabeth J. Ilett,Alan Melcher,Richard G. Vile	57
12	Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy 2015 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown),Kevin G. Shim,Michael P. Grams,Karishma Rajani,Rosa María Díaz,Keith M. Furutani,Jill Thompson,Kenneth R. Olivier,Sean S. Park,Svetomir N. Markovic,Hardev Pandha,Alan Melcher,Kevin J. Harrington,Shane Zaidi,Richard G. Vile	16
13	69. Combination Therapy of Reovirus and PD-1 Blockade Effectively Establishes Tumor Control Via Innate and Adaptive Immune Responses 2015 ·Molecular Therapy ·Karishma Rajani,Kevin G. Shim,Christopher Parrish,Elizabeth J. Ilett,Tim Kottke,José S. Pulido,Jill Thompson,Hardev Pandha,Kevin J. Harrington,Alan Melcher,Fiona Errington‐Mais,Rosa María Díaz,Matt Coffey,Shane Zaidi,Richard G. Vile	7
14	Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis 2015 ·Journal of Virology ·(unknown),Jingfang Liu,Karishma Rajani,Ralph B. D’Agostino,Douglas S. Lyles,Mercedes Porosnicu	24
15	Abstract B88: Combination therapy of reovirus and checkpoint inhibition 2015 ·Cancer Immunology Research ·Shane Zaidi,Kevin G. Shim,Karishma Rajani,Rosa María Díaz,Elizabeth J. Ilett,Timothy Kottke,(unknown),Peter J. Selby,Kevin J. Harrington,Hardev Pandha,Alan Melcher,Matt Coffey,Richard G. Vile	1
16	Abstract 1360: Combination therapy of reovirus and PD-1 blockade effectively establishes tumor control via innate and adaptive immune responses 2015 ·Cancer Research ·Karishma Rajani,Christopher Parrish,Kevin G. Shim,Elizabeth J. Ilett,Fiona Errington‐Mais,Jill Thompson,Tim Kottke,(unknown),Peter J. Selby,Hardev Pandha,Kevin J. Harrington,Alan Melcher,Matt Coffey,Shane Zaidi,Richard G. Vile	1
17	The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site 2014 ·Molecular Therapy ·Vanesa Alonso-Camino,Karishma Rajani,Timothy Kottke,(unknown),Shane Zaidi,Jill Thompson,José S. Pulido,Elizabeth J. Ilett,Oliver Donnelly,Peter J. Selby,Hardev Pandha,Alan Melcher,Kevin J. Harrington,Rosa María Díaz,Richard G. Vile	14
18	Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents 2014 ·Molecular Therapy ·Shane Zaidi,(unknown),Kevin G. Shim,Elizabeth J. Ilett,Karishma Rajani,Christopher Parrish,Nicolas Boisgerault,Tim Kottke,Jill Thompson,Esteban Celis,José S. Pulido,Peter J. Selby,Hardev Pandha,Alan Melcher,Kevin J. Harrington,Richard G. Vile	11
19	Preservation of Dendritic Cell Function during Vesicular Stomatitis Virus Infection Reflects both Intrinsic and Acquired Mechanisms of Resistance to Suppression of Host Gene Expression by Viral M Protein 2013 ·Journal of Virology ·(unknown),Maryam Ahmed,(unknown),Karishma Rajani,Elizabeth M. Hiltbold,Douglas S. Lyles	10
20	Complexes of Vesicular Stomatitis Virus Matrix Protein with Host Rae1 and Nup98 Involved in Inhibition of Host Transcription 2012 ·PLoS Pathogens ·Karishma Rajani,(unknown),Margie O. McKenzie,David A. Horita,Jeff W. Chou,Douglas S. Lyles	59

About Karishma Rajani

Karishma Rajani is a scholar working on Biotechnology, Immunology and Genetics, having authored 22 papers that have together received 500 indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Genetics (320 citations), Oncology (294 citations) and Biotechnology (72 citations). Karishma Rajani has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard G. Vile, Alan Melcher, Elizabeth J. Ilett, Jill Thompson, Shane Zaidi, Kevin G. Shim, Kevin J. Harrington, Timothy Kottke, Douglas S. Lyles and Matt Coffey. Their work appears in journals such as Cancer Research, Journal of Virology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact